References
Watts GDJ, Wymer J, Kovach MJ et al (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381. doi:10.1038/ng1332
Johnson JO, Mandrioli J, Benatar M et al (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68:857–864. doi:10.1016/j.neuron.2010.11.036
Shi Z, Hayashi YK, Mitsuhashi S et al (2012) Characterization of the Asian myopathy patients with VCP mutations. Eur J Neurol 19:501–509. doi:10.1111/j.1468-1331.2011.03575.x
Schröder R, Watts GDJ, Mehta SG et al (2005) Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 57:457–461. doi:10.1002/ana.20407
Oba H, Yagishita A, Terada H et al (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. 64:2050–2055. doi:10.1212/01.WNL.0000165960.04422.D0
Quattrone A, Nicoletti G, Messina D et al (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214–221. doi:10.1148/radiol.2453061703
Mehta SG, Khare M, Ramani R et al (2013) Genotype–phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin Genet 83:422–431. doi:10.1111/cge.12000
González-Pérez P, Cirulli ET, Drory VE et al (2012) Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology 79:2201–2208. doi:10.1212/WNL.0b013e318275963b
Siuda J, Fujioka S, Wszolek ZK (2014) Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat Disord 20:957–964. doi:10.1016/j.parkreldis.2014.06.004
Chan N, Le C, Shieh P, Mozaffar T et al (2012) Valosin-containing protein mutation and Parkinson’s disease. Parkinsonism Relat Disord 18:107–109. doi:10.1016/j.parkreldis.2011.07.006
Acknowledgements
We thank all of the participants and the patient for their participation in our study.
Author contributions
MF, KK and NH designed the study. MF and KK wrote the draft. MF, KK, SF, MT, KY and YL contributed to the acquisition and analysis of the clinical data and specimens, and the interpretation of the clinical data: Pathological Analysis: ST and MT. Genetic Analysis: YL. SF, MT, KY, YL and NH reviewed and critiqued the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was partially funded by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23111003, 23591269, 24390224, 26461319).
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical standard
All procedures used in this research were approved by the Ethical Committee of Juntendo University Hospital, and were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from a participant included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 a Eye movement. b Facial expression. c Rigidity of the upper limb. d Finger taps. e Rapid alternating movement of hands. f Rising from a chair. g Gait. h Postural stability. (M4V 18712 kb)
Rights and permissions
About this article
Cite this article
Fujimaki, M., Kanai, K., Funabe, S. et al. Parkinsonism in a patient with valosin-containing protein gene mutation showing: a case report. J Neurol 264, 1284–1286 (2017). https://doi.org/10.1007/s00415-017-8467-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-017-8467-2